Australia « Science and Enterprise

Online App Encourages Abstinence in Alcohol Addiction

By Alan, on November 5th, 2020%

Results from a clinical trial show users of an online abstinence training app are less likely to relapse in alcohol consumption than sham training app users. . . . → Read More: Online App Encourages Abstinence in Alcohol Addiction

Infographic – Mental Health Effects of Pandemic

By Alan, on August 8th, 2020%

Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic

Advanced Solid Tumor Precision Meds. Trial Begins

By Alan, on July 23rd, 2020%

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Biotech IDs Potent Covid-19 Antibodies

By Alan, on July 2nd, 2020%

A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Biotech IDs Potent Covid-19 Antibodies

Drug Maker Licenses Low-Dose Vaccine Patch

By Alan, on May 28th, 2020%

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

TB Vaccine Test on Covid-19 Expanding to Europe

By Alan, on May 5th, 2020%

A clinical trial testing a current tuberculosis vaccine among health care workers in Australia is expanding in that country and to two European countries. . . . → Read More: TB Vaccine Test on Covid-19 Expanding to Europe

Case Study Maps Covid-19 Immune Response

By Alan, on March 17th, 2020%

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Patch Delivers Low-Dose Vaccine with Full-Dose Power

By Alan, on March 17th, 2020%

A clinical trial shows a polymer patch with one-sixth of the usual influenza vaccine dose generates about the same immune reaction as a full-dose injection. . . . → Read More: Patch Delivers Low-Dose Vaccine with Full-Dose Power

Intl Group Calls for More Coronavirus Vaccines

By Alan, on February 4th, 2020%

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines

Stem Cell Transplants Offer Nerve Pain Relief

By Alan, on January 24th, 2020%

Researchers in Australia show in tests with lab mice that transplanted adult stem cells can provide long-term relief from chronic pain caused by nerve damage. . . . → Read More: Stem Cell Transplants Offer Nerve Pain Relief

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise